CDK4 and esophageal squamous cell carcinoma: For example, Jiang et al. reported that miR-1 was downregulated and inhibited cell proliferation of esophageal squamous cell carcinoma in vivo and in vitro by downregulating MET, cyclin D1, and CDK4 [18].